Hormone Therapy News

Menopausal hormone therapy significantly decreased the odds of death from COVID-19 among postmenopausal women, according to data from a nationwide registry-based study.

The Endocrine Society is condemning a new directive issued by Texas Gov. Greg Abbott defining gender care for adolescents as “child abuse,” according to a press release from the organization.

Testosterone undecanoate injected at 8-week intervals for men with hypogonadism may reduce fluctuations and increase mean testosterone levels compared with a 10-week dose regimen, according to data from a modeling study.

Type 2 diabetes incidence rates do not differ between transgender adults after starting hormone therapy and cisgender adults, according to study findings published in The Journal of Clinical Endocrinology & Metabolism.

Transgender men receiving testosterone have higher total volumetric bone mineral density than cisgender women, whereas transgender women on estradiol have lower volumetric BMD compared with cisgender men, according to study data.

Dermatologists should be aware of clinical and mental health parameters when treating transgender patients for acne, according to a recommendation statement.

One-third of acromegaly and growth hormone deficiency studies report discrepancies between patient-reported outcomes and biochemical outcomes, with many using unvalidated and poorly reported outcome measures, data from a meta-analysis show.

Endocrine Today editors have compiled the top cover stories published in 2021.

Nearly one-quarter of men reporting low libido and a total testosterone measurement indicating likely hypogonadism did not receive a prescription for testosterone replacement therapy, according to a U.K. database analysis.

Transgender people prescribed gender-affirming hormone therapy were no more likely to develop type 2 diabetes compared with cisgender adults, according to an analysis of electronic health records data.